Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes

Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer

(2015) M. Mego et al.   BMC CANCER

Oct-4 and nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients

(2015) Dan Wang et al.   Oncotarget

Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression

(2014) A. Satelli et al.   CLINICAL CANCER RESEARCH

Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition

(2014) Lo-Lin Tsai et al.   PLoS One

Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients: A Meta-analysis

(2013) Jian Song et al.   Asian Pacific Journal of Cancer Prevention

EMT as the ultimate survival mechanism of cancer cells

(2012) Neha Tiwari et al.   SEMINARS IN CANCER BIOLOGY

High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis

(2012) Parichut Thummarati   WORLD JOURNAL OF GASTROENTEROLOGY

6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation

(2010) H Ling et al.   BRITISH JOURNAL OF PHARMACOLOGY

Inhibition of Human Breast Cancer Cell Invasion by siRNA Against Urokinase-Type Plasminogen Activator

(2010) Hong-Yan Huang et al.   CANCER INVESTIGATION

Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling

(2009) Minji Jo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development

(2008) Lidiya S. Orlichenko et al.   CLINICAL & EXPERIMENTAL METASTASIS

Matrix metalloproteinase-9 Inhibition Down-Regulates Radiation-Induced Nuclear Factor- B Activity Leading to Apoptosis in Breast Tumors

(2008) S. Kunigal et al.   CLINICAL CANCER RESEARCH